Cargando…
Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
Cellular metabolism of cancer cell is generally recognized to provide energy for facilitating tumor growth, but little is known about the aberrant metabolism in tumor progression and its prognostic value. Here, we applied integrated genomic approach to uncover the aberrant expression of metabolic en...
Autores principales: | Yeh, Hsi-Wen, Lee, Szu-Shuo, Chang, Chieh-Yu, Hu, Chun-Mei, Jou, Yuh-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652811/ https://www.ncbi.nlm.nih.gov/pubmed/29100421 http://dx.doi.org/10.18632/oncotarget.20774 |
Ejemplares similares
-
Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma
por: Lian, Yi-Fan, et al.
Publicado: (2018) -
Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma
por: Ridder, Dirk Andreas, et al.
Publicado: (2021) -
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014) -
Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma
por: Wang, Zhangding, et al.
Publicado: (2021) -
Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)